<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Losartan; Valsartan; Candesartan; Irbesartan; Angiotensin-II receptor antagonists; Antihypertensives: angiotensin-II receptor antagonists; Eprosartan; Olmesartan; Telmisartan" /><meta name="IX" content="Losartan; Valsartan; Candesartan; Irbesartan; Angiotensin-II receptor antagonists; Antihypertensives: angiotensin-II receptor antagonists; Eprosartan; Olmesartan; Telmisartan" /><title>2.5.5.2 Angiotensin-II receptor antagonists: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="27513.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="27513.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=27513.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2534.htm">2.5 Hypertension and heart failure</a> &gt; <a href="27510.htm">2.5.5 Drugs affecting the renin-angiotensin system</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2605.htm" title="Previous: TRANDOLAPRIL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="64864.htm" title="Next: CANDESARTAN CILEXETIL">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_27513">2.5.5.2 Angiotensin-II receptor antagonists</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i107.htm" title="Go to appendix 1">Angiotensin-II Receptor Antagonists</a>).</div><div><p><b>Candesartan</b>, <b>eprosartan</b>, <b>irbesartan</b>, <b>losartan</b>, <b>olmesartan</b>, <b>telmisartan</b>, and <b>valsartan</b> are
angiotensin-II receptor antagonists with many properties similar to
those of the ACE inhibitors. However, unlike ACE inhibitors, they
do not inhibit the breakdown of bradykinin and other kinins, and thus
are less likely to cause the persistent dry cough which can complicate
ACE inhibitor therapy. They are therefore a useful alternative
for patients who have to discontinue an ACE inhibitor because of persistent
cough.</p><p>An angiotensin-II receptor antagonist may be used as an alternative
to an ACE inhibitor in the management of heart failure (<a title="sub-section: Drugs affecting the renin-angiotensin system" href="27510.htm#_27510">section 2.5.5</a>) or diabetic
nephropathy (<a title="sub-section: Treatment of diabetic nephropathy and neuropathy" href="4201.htm#_4201">section 6.1.5</a>).</p><div class="cAZ" id="_27513.1"><h2>Cautions</h2> <p class="cAX">Angiotensin-II receptor antagonists
should be used with caution in renal artery stenosis (see also Renal Effects under ACE Inhibitors, <a title=" Angiotensin-converting enzyme inhibitors" href="2578.htm#_2578">section 2.5.5.1</a>). Monitoring of plasma-potassium concentration is advised, particularly in the elderly and in patients
with renal impairment; lower initial doses
may be appropriate in these patients. Angiotensin-II receptor antagonists
should be used with caution in aortic or mitral valve stenosis and in hypertrophic
cardiomyopathy. Those with primary aldosteronism, and Afro-Caribbean patients (particularly those with
left ventricular hypertrophy), may not benefit from an angiotensin-II
receptor antagonist. <b>Interactions:</b> Appendix 1 (angiotensin-II receptor antagonists).</p></div><div id="_204167"><div class="cAZ"><h2>Pregnancy</h2> <p class="cAX">Angiotensin-II receptor antagonists
should be avoided in pregnancy unless essential. They may adversely
affect fetal and neonatal blood pressure control and renal function;
skull defects and oligohydramnios have also been reported.</p></div></div><div id="_204168"><div class="cAZ"><h2>Breast-feeding</h2> <p class="cAX">Information on the use of angiotensin-II
receptor antagonists in breast-feeding is limited. They are not recommended
in breast-feeding and alternative treatment options, with better established
safety information during breast-feeding, are available. </p></div></div><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Side-effects are usually mild. Symptomatic
hypotension including dizziness may occur, particularly in patients
with intravascular volume depletion (e.g. those taking high-dose diuretics).
Hyperkalaemia occurs occasionally; angioedema has also been reported
with some angiotensin-II receptor antagonists.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_64864"><a href="64864.htm" title="CANDESARTAN CILEXETIL">CANDESARTAN CILEXETIL</a></li><li id="_85176"><a href="85176.htm" title="EPROSARTAN">EPROSARTAN</a></li><li id="_64883"><a href="64883.htm" title="IRBESARTAN">IRBESARTAN</a></li><li id="_27526"><a href="27526.htm" title="LOSARTAN POTASSIUM">LOSARTAN POTASSIUM</a></li><li id="_127965"><a href="127965.htm" title="OLMESARTAN MEDOXOMIL">OLMESARTAN MEDOXOMIL</a></li><li id="_81217"><a href="81217.htm" title="TELMISARTAN">TELMISARTAN</a></li><li id="_56945"><a href="56945.htm" title="VALSARTAN">VALSARTAN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2605.htm">Previous: TRANDOLAPRIL</a> | <a class="top" href="27513.htm#">Top</a> | <a accesskey="]" href="64864.htm">Next: CANDESARTAN CILEXETIL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>